Form 4: Relay Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Peter Rahmer, See remarks of Relay Therapeutics, Inc., sold 4,508 shares of common stock on August 26, 2026 for $20.03 per share.
Summary
- Open-market sale: disposed of 4,508 Common Stock at $20.03 ($90,295) on August 26, 2026; holds 223,657 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $90,295 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Peter Rahmer — Officer (See remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Open-market sale | Common Stock | 4,508 | $20 | $90.3K | 223,657 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Open-market sale (4,508 shares) |
Keywords
insider transaction, Form 4, RLAY, Relay Therapeutics, Inc., bearish, Peter Rahmer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.